To Top

Search By Topic

Formulation

57 Articles available
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
Acquisition

Almac Expands Analytical Services with BioClin Laboratories Acquisition

PAO-M11-17-NI-033
Drug Development

Small Molecule Cancer Combination Therapy Receives Second Patent

PAO-M11-17-NI-031
Topical

New NSAID Topical Gels Penetrate Three Times Faster

PAO-M11-17-NI-004
Drug Delivery

Subdermal Parkinson’s Implant Treatment in Trials

PAO-M10-17-NI-024
Formulation

Polyphor AG: Polyphor Launches the Development of an Inhaled Formulation of its Antibiotic Murepavadin

PR-M10-17-NI-004
Innovation

Bone Marrow Transplant Therapy Gets Monoclonal Antibody Boost

PAO-M10-17-NI-015
Drug Development

New Insulin Formulation Improves Mealtime Glycemic Control

PAO-M10-17-NI-011
Drug Development

Biotechs Collaborate to Develop Multifunctional Cancer Immunotherapies

PAO-M10-17-NI-009
Formulation

DNA Binding Protein May Increase Ovarian Cancer Survival

PAO-M09-17-NI-034
FDA Approval

FDA Approves Grifols’ Prolastin-C Liquid

PAO-M09-17-NI-032
Abuse Deterrence

Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations

PAP-Q3-17-CL-003
Continuous Manufacturing

Innovation and Formulation

Thomas Hofmaier, Head of Business Unit Process Technology Pharma, Glatt Air Techniques

PTV-M03-17-IN-005
CDMO

Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions

PAO-M04-17-NI-014
Excipients

Making it Simple

Ken Seufert, Managing Director, Meggle USA

PTV-M11-16-AP-030
Formulation

Focusing on Patient Compliance

Brian Wilson, Technical Development Manager, SPI Pharma

PTV-M01-17-NS-011
Formulation

Partnering for Formulation Development

Elsie Melsopp, Director of Formulation, Alcami

PTV-M11-16-AP-001
Formulation

Innovative Drug Delivery Technology

Kevin Haehl, General Manager, North America, Unither Pharmaceuticals

PTV-M11-16-AP-006
CDMO

Choosing the Right Pathway

Ken Phelps, President & CEO, Camargo

PTV-M11-16-AP-007
CDMO

Servier Offers Quality Service

Gwenael Servant, Managing Director, Servier CDMO

PTV-M11-16-AP-012
Formulation

Enhancement and Availability

Edward Rudnic, CEO, Dispersol

PTV-M11-16-AP-015
Equipment

Freund Vector Can’t Go Wrong with Granurex

Shawn Engels, Senior Process Development Engineer, Freund Vector

PTV-M11-16-AP-017
Formulation

Expanding Capabilities

Frank Sorce, Vice President of Business Development, UPM Pharmaceuticals

PTV-M11-16-AP-023
CDMO

Understanding Solid State Properties for Formulation Success

PAO-M04-17-NI-001
API

Energizing Client Portfolios with Patient-Friendly Dosage Forms

PAP-Q1-17-CL-001
Excipients

Spending on Excipients Grows & Diversifies

PAP-Q1-17-FA-004
CDMO

Operational Excellence in Outsourced Fill-Finish Services

PAP-Q1-17-IC-001
//Fix for text overflow in cards